Shares of this under-the-radar weight-loss drug play could double, says Leerink Partners
- Posted on September 9, 2025
- By CNBC
- 4 Views
Shares of this under-the-radar weight-loss drug play could double, says Leerink Partners
The investment firm initiated coverage of the biopharma stock at a outperform rating.
